One possible reason is that ATX, lipid phosphate phosphatase, and non-GPCR LPARs signaling have been implicated in tumor growth and metastasis, suggesting the limitation by attenuating LPA-GPCR signaling only. The gene discussed is ENPP2; the disease is neoplasm.